“…EF is sometimes associated with hematologic diseases, particularly with aplastic anemia (AA) (n = 19), 2 , 13 , 15 , 22 , 24 , 30 , 33 , 38 , 57 , 58 , 73 , 77 , 89 , 95 , 111 , 117 , 128 but also with T-cell lymphoma (n = 5), 27 , 36 , 65 , 72 , 83 cutaneous T-cell lymphoma (n = 1), 25 Hodgkin disease (n = 3), 84 , 90 , 98 myeloproliferative syndromes (n = 3), 61 , 75 , 85 myelomonocytic leukemia (n = 2), 75 , 85 chronic lymphocytic leukemia (n = 2), 12 , 75 multiple myeloma (n = 1), 68 and myeloblastic leukemia (n = 1), 90 and, less commonly, with solid tumors such as breast cancer (n = 5), 12 , 90 , 109 , 127 choroidal melanoma (n = 1), 125 colorectal cancer (n = 1), 94 and prostate cancer (n = 1). 90 Diffuse EF has also been reported in association with autoimmune disorders, such as Hashimoto thyroiditis (n = 6), 2 , 5 , 13 , 59 , 114 systemic lupus erythematosus (n = 4), 6 , 43 , 45 , 74 Crohn disease (n = 1), 82 Graves disease (n = 1), 114 glomerulonephritis (n = 1), 63 rheumatoid arthritis (n = 1), 81 type 1 diabetes (n = 1), 46 and autoimmune cytopenias, including autoimmune hemolytic anemia (n = 2), 5 , 44 immune thrombocytopenic purpura (n = 2), 5 , 111 amegakaryocytic thrombocyt...…”